Insights

Top Analyst Bullish on Adaptimmune Therapeutics PLC – ADR (ADAP) “Major” Share Drivers Set to Hit This Year

Cowen’s Eric Schmidt gives a vote of confidence to ADAP on back of yesterday’s fourth quarter financial and pipeline update.

Amazon.com, Inc. (AMZN) and Facebook Inc (FB) Could Emerge as the Dominant Forces in the TV Sports Rights Universe

GBH Insights’ Daniel Ives makes a case for AMZN and FB as two standout prospective players in sports programming.

Dicks Sporting Goods Inc (DKS): More Headwinds Ahead

RBC Capital’s Scot Ciccarelli delivers a cautious perspective on DKS shares following a mixed bag of a fourth quarter performance.

Where Will Amazon.com, Inc. (AMZN) Pick Its Next Headquarters? Wells Fargo Shares Two Cents

Wells Fargo’s Ken Sena believes Boston has the best odds for Amazon’s HQ2; here’s why:

TherapeuticsMD Inc (TXMD): Mega Metamorphosis Ahead? This Analyst Says Yes

Oppenheimer’s Jay Olson is liking the setup of TXMD shares more and more amid major commercial potential.

Analyst Cuts Price Target on Synergy Pharmaceuticals Inc (SGYP); All Chips Are Riding on Trulance Uptake

Though Cantor’s William Tanner keeps SGYP’s capital needs and prospective dilution in mind, he is confident on Trulance’s uptake in the market.

Netflix, Inc. (NFLX) Takes “Major Credibility Step” Thanks to Oscar Buzz, Praises Daniel Ives

GBH Insights’ Daniel Ives says this video streaming giant is carving a good reputation for itself in Hollywood as a respectable platform.

Square Inc (SQ) Draws a Price Target Boost Following 4Q Showcase

Square Inc (NYSE:SQ) dealt a strong hand for its fourth quarter, with CEO Jack Dorsey’s company outclassing Street-wide expectations. Stifel analyst Scott Devitt …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts